KROS - Keros Therapeutics Inc

11.27
-0.310   -2.751%

Share volume: 625,841
Last Updated: 03-11-2026
Pharmaceutical Products/Pharmaceutical Preparations: 3.16%

PREVIOUS CLOSE
CHG
CHG%
$11.58
-0.31
-0.03%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 03-31-2024 06-30-2024 09-30-2024 12-31-2024 03-31-2025 09-30-2025 12-31-2025
Fiscal Quarter Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q3 2025 Q4 2025
Report Date 05-08-2024 08-07-2024 11-06-2024 02-26-2025 05-06-2025 11-05-2025 03-04-2026
Total revenue 83.000 K 37.000 K 388.000 K 3.042 M 211.246 M 14.262 M 385.000 K
Cost of revenue 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Gross profit 83.000 K 37.000 K 388.000 K 3.042 M 211.246 M 14.262 M 385.000 K
    -55.42% 948.65% 684.02% 6,844.31% -93.25% -97.30%  
Operating expenses 48.566 M 50.476 M 59.045 M 56.296 M 59.206 M 29.646 M 29.655 M
Selling general and admin 10.308 M 9.961 M 9.820 M 10.665 M 10.497 M 10.127 M 11.743 M
Research and development 38.258 M 40.515 M 49.225 M 45.631 M 48.709 M 19.519 M 17.912 M
Total expenses 48.566 M 50.476 M 59.045 M 56.296 M 59.206 M 29.646 M 29.655 M
    3.93% 16.98% -4.66% 5.17% -49.93% 0.03%  
Operating income -48.483 M -50.439 M -58.657 M -53.254 M 152.040 M -15.384 M -29.270 M
Ebit -48.920 M -50.635 M -58.749 M -53.483 M 151.702 M -15.637 M -28.997 M
Pretax income -43.114 M -45.257 M -52.956 M -45.726 M 158.494 M -8.704 M -24.975 M
    4.97% 17.01% -13.65% -446.62% -105.49% 186.94%  
Income tax 0.000 0.000 0.000 0.000 10.043 M -1.424 M -1.514 M
Net income basic 0.000 0.000 0.000 0.000 0.000 0.000 0.000
                 
Net income -43.114 M -45.257 M -52.956 M -46.026 M 148.451 M -7.280 M -23.461 M
    -4.97% -17.01% 13.09% 422.54% -104.90% -222.27%